2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione

C25H18BrN3O7 — CID 98122237

IUPAC2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione
SMILESCOc1ccc(OC)c([C@H]2[C@H](N3C(=O)c4ccc([N+](=O)[O-])cc4C3=O)C(=O)N2c2ccc(Br)cc2)c1
InChIInChI=1S/C25H18BrN3O7/c1-35-16-8-10-20(36-2)19(12-16)21-22(25(32)27(21)14-5-3-13(26)4-6-14)28-23(30)17-9-7-15(29(33)34)11-18(17)24(28)31/h3-12,21-22H,1-2H3/t21-,22-/m0/s1
InChIKeyZMDLCGMRUMXOOP-VXKWHMMOSA-N
MW552.34 g/mol
LogP4.13
Rot. Bonds6

About 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione

2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione (PubChem CID 98122237) has the molecular formula C25H18BrN3O7 and a molecular weight of 552.34 g/mol. Its IUPAC name is 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione.

Molecular Properties

Compound Name2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione
PubChem CID98122237
Molecular FormulaC25H18BrN3O7
Molecular Weight552.34 g/mol
Exact Mass551.03
IUPAC Name2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione
SMILESCOc1ccc(OC)c([C@H]2[C@H](N3C(=O)c4ccc([N+](=O)[O-])cc4C3=O)C(=O)N2c2ccc(Br)cc2)c1
InChIInChI=1S/C25H18BrN3O7/c1-35-16-8-10-20(36-2)19(12-16)21-22(25(32)27(21)14-5-3-13(26)4-6-14)28-23(30)17-9-7-15(29(33)34)11-18(17)24(28)31/h3-12,21-22H,1-2H3/t21-,22-/m0/s1
InChIKeyZMDLCGMRUMXOOP-VXKWHMMOSA-N
XLogP4.13
TPSA119.29 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500552.34
LogP ≤ 54.13
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione?
The IUPAC name of 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione (CID 98122237) is 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione.
What is the SMILES notation for 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione?
The canonical SMILES for 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione is COc1ccc(OC)c([C@H]2[C@H](N3C(=O)c4ccc([N+](=O)[O-])cc4C3=O)C(=O)N2c2ccc(Br)cc2)c1.
What is the InChIKey of 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione?
The InChIKey is ZMDLCGMRUMXOOP-VXKWHMMOSA-N. The full InChI is InChI=1S/C25H18BrN3O7/c1-35-16-8-10-20(36-2)19(12-16)21-22(25(32)27(21)14-5-3-13(26)4-6-14)28-23(30)17-9-7-15(29(33)34)11-18(17)24(28)31/h3-12,21-22H,1-2H3/t21-,22-/m0/s1.
What are the key properties of 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione?
2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione has a molecular weight of 552.34 g/mol, XLogP of 4.13, 6 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2S,3S)-1-(4-bromophenyl)-2-(2,5-dimethoxyphenyl)-4-oxoazetidin-3-yl]-5-nitroisoindole-1,3-dione is sourced from PubChem (CID 98122237), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).